In vivo homologous sequence targeting in eukaryotic cells
OwnerDavid A. Zarling, Elissa P. Senainventors
Life of this patent
Estimating the term…
Loading patent…
OwnerDavid A. Zarling, Elissa P. Senainventors
Estimating the term…
The invention relates to methods for targeting an exogenous polynucleotide or exogenous complementary polynucleotide pair to a predetermined endogenous DNA target sequence in a eukaryotic cell by homologous pairing, particularly for altering an endogenous DNA sequence, such as a chromosomal DNA sequence, typically by targeted homologous recombination. In certain embodiments, the invention relates to methods for targeting an exogenous polynucleotide having a linked chemical substituent to a predetermined endogenous DNA sequence in a metabolically active eukaryotic cell, generating a DNA sequence-specific targeting of one or more chemical substituents in an intact nucleus of a metabolically active eukaryotic cell, generally for purposes of altering a predetermined endogenous DNA sequence in the cell. The invention also relates to compositions that contain exogenous targeting polynucleotides, complementary pairs of exogenous targeting polynucleotides, chemical substituents of such polynucleotides, and recombinase proteins used in the methods of the invention.
A method for targeting and altering, by homologous recombination, a pre-selected target DNA sequence in a eukaryotic cell to make a targeted sequence modification, said method comprising the steps of:
A composition for producing a targeted modification of an endogenous DNA sequence, comprising a targeting polynucleotide and a recombinase.
A composition for producing a targeted sequence modification of a human disease allele, comprising a targeting polynucleotide containing a corrected sequence and a recombinase.
A kit for therapy, monitoring, or prophylaxis of a genetic disease comprising a recombinase and a targeting polynucleotide.
A method for treating a disease of a animal harboring a disease allele, comprising administering to the animal a composition consisting essentially of a targeting polynucleotide for correcting the disease allele and a recombinase.
Dependencies are inferred from the claim text.